☰

David R. Raleigh, Ph.D. - Publications

Affiliations: 
2010 Pathology University of Chicago, Chicago, IL 
Area:
Cell Biology, Molecular Biology, Bioinformatics Biology
Tree Info Similar researchers PubMed Report error

103 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Liu SJ, Casey-Clyde T, Cho NW, Swinderman J, Pekmezci M, Dougherty MC, Foster K, Chen WC, Villanueva-Meyer JE, Swaney DL, Vasudevan HN, Choudhury A, Pak J, Breshears JD, Lang UE, ... ... Raleigh DR, et al. Epigenetic reprogramming shapes the cellular landscape of schwannoma. Nature Communications. 15: 476. PMID 38216587 DOI: 10.1038/s41467-023-40408-5  0.617
2024 Vasudevan HN, Payne E, Delley CL, John Liu S, Mirchia K, Sale MJ, Lastella S, Nunez MS, Lucas CG, Eaton CD, Casey-Clyde T, Magill ST, Chen WC, Braunstein SE, Perry A, ... ... Raleigh DR, et al. Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. Nature Communications. 15: 477. PMID 38216572 DOI: 10.1038/s41467-024-44755-9  0.56
2024 Umbach G, Tran EB, Eaton CD, Choudhury A, Morshed R, Villanueva-Meyer JE, Theodosopoulos PV, Magill ST, McDermott MW, Raleigh DR, Goldschmidt E. Epidemiology, Genetics, and DNA Methylation Grouping of Hyperostotic Meningiomas. Operative Neurosurgery (Hagerstown, Md.). PMID 38189372 DOI: 10.1227/ons.0000000000001052  0.559
2023 Hadad S, Gupta R, Oberheim Bush NA, Taylor JW, Villanueva-Meyer JE, Young JS, Wu J, Ravindranathan A, Zhang Y, Warrier G, McCoy L, Shai A, Pekmezci M, Perry A, Bollen AW, ... ... Raleigh DR, et al. "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade. Acta Neuropathologica. 147: 3. PMID 38079020 DOI: 10.1007/s00401-023-02654-1  0.541
2023 Chen WC, Choudhury A, Youngblood MW, Polley MC, Lucas CG, Mirchia K, Maas SLN, Suwala AK, Won M, Bayley JC, Harmanci AS, Harmanci A, Klisch TJ, Nguyen MP, Vasudevan HN, ... ... Raleigh DR, et al. Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Nature Medicine. PMID 37944590 DOI: 10.1038/s41591-023-02586-z  0.631
2023 Chen WC, Lucas CG, Magill ST, Rogers CL, Raleigh DR. Radiotherapy and radiosurgery for meningiomas. Neuro-Oncology Advances. 5: i67-i83. PMID 37711972 DOI: 10.1093/noajnl/vdac088  0.569
2023 Choudhury A, Cady MA, Lucas CG, Najem H, Phillips JJ, Palikuqi B, Zakimi N, Joseph T, Birrueta JO, Chen WC, Bush NAO, Hervey-Jumper SL, Klein OD, Toedebusch CM, Horbinski CM, ... ... Raleigh DR, et al. NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy. Biorxiv : the Preprint Server For Biology. PMID 37503127 DOI: 10.1101/2023.07.10.548456  0.568
2023 Nandoliya KR, Sadagopan NS, Thirunavu V, Houskamp EJ, Karras CL, Chaliparambil RK, Sriram N, Jamshidi P, Raleigh DR, Lukas RV, Magill ST. Post-Surgical Prognosis of Patients with Pineoblastoma: A Systematic Review and Individual Patient Data Analysis with Trends over Time. Cancers. 15. PMID 37444483 DOI: 10.3390/cancers15133374  0.571
2023 Lucas CH, Mirchia K, Seo K, Najem H, Chen W, Zakimi N, Choudhury A, Liu SJ, Phillips J, Magill S, Horbinski C, Solomon D, Perry A, Vasudevan H, Heimberger A, ... Raleigh D, et al. Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution. Research Square. PMID 37292686 DOI: 10.21203/rs.3.rs-2921804/v1  0.581
2023 Raleigh D, Chen W, Choudhury A, Youngblood M, Polley MY, Lucas CH, Mirchia K, Maas S, Suwala A, Won M, Bayley J, Harmanci A, Harmanci A, Klisch T, Nguyen M, et al. Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Research Square. PMID 36993741 DOI: 10.21203/rs.3.rs-2663611/v1  0.635
2023 Eaton C, Avalos L, Liu SJ, Casey-Clyde T, Bisignano P, Lucas CH, Stevenson E, Choudhury A, Vasudevan H, Magill S, Krogan N, Villanueva-Meyer J, Swaney D, Raleigh D. MerlinS13 phosphorylation controls meningioma Wnt signaling and magnetic resonance imaging features. Research Square. PMID 36993679 DOI: 10.21203/rs.3.rs-2577844/v1  0.579
2023 Khan AB, English CW, Chen WC, Athukuri P, Bayley JC, Brandt VL, Shetty A, Hadley CC, Choudhury A, Lu HC, Harmanci AO, Harmanci AS, Magill ST, Raleigh DR, Klisch TJ, et al. Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma. Acta Neuropathologica. PMID 36729132 DOI: 10.1007/s00401-023-02543-7  0.499
2022 Chen WC, Perlow HK, Choudhury A, Nguyen MP, Mirchia K, Youngblood MW, Lucas CG, Palmer JD, Magill ST, Raleigh DR. Radiotherapy for meningiomas. Journal of Neuro-Oncology. PMID 36315366 DOI: 10.1007/s11060-022-04171-9  0.579
2022 Nguyen MP, Morshed RA, Dalle Ore CL, Cummins DD, Saggi S, Chen WC, Choudhury A, Ravi A, Raleigh DR, Magill ST, McDermott MW, Theodosopoulos PV. Supervised machine learning algorithms demonstrate proliferation index correlates with long-term recurrence after complete resection of WHO grade I meningioma. Journal of Neurosurgery. 1-9. PMID 36303473 DOI: 10.3171/2022.4.JNS212516  0.572
2022 Choudhury A, Chen WC, Lucas CG, Bayley JC, Harmanci AS, Maas SLN, Santagata S, Klisch T, Perry A, Bi WL, Sahm F, Patel A, Magill ST, Raleigh DR. Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features. Neuro-Oncology. PMID 36227281 DOI: 10.1093/neuonc/noac224  0.542
2022 Lucas CG, Sloan EA, Gupta R, Wu J, Pratt D, Vasudevan HN, Ravindranathan A, Barreto J, Williams EA, Shai A, Whipple NS, Bruggers CS, Maher O, Nabors B, Rodriguez M, ... ... Raleigh DR, et al. Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. Acta Neuropathologica. PMID 35945463 DOI: 10.1007/s00401-022-02478-5  0.576
2022 Gleason JM, Klass SH, Huang P, Ozawa T, Santos RA, Fogarty MM, Raleigh DR, Berger MS, Francis MB. Intrinsically Disordered Protein Micelles as Vehicles for Convection-Enhanced Drug Delivery to Glioblastoma Multiforme. Acs Applied Bio Materials. PMID 35857070 DOI: 10.1021/acsabm.2c00215  0.347
2022 Vasudevan HN, Choudhury A, Hilz S, Villanueva-Meyer JE, Chen WC, Lucas CG, Braunstein SE, Oberheim Bush NA, Butowski N, Pekmezci M, McDermott MW, Perry A, Solomon DA, Magill ST, Raleigh DR. Intratumor and informatic heterogeneity influence meningioma molecular classification. Acta Neuropathologica. PMID 35759011 DOI: 10.1007/s00401-022-02455-y  0.517
2022 Choudhury A, Magill ST, Eaton CD, Prager BC, Chen WC, Cady MA, Seo K, Lucas CG, Casey-Clyde TJ, Vasudevan HN, Liu SJ, Villanueva-Meyer JE, Lam TC, Pu JK, Li LF, ... ... Raleigh DR, et al. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nature Genetics. PMID 35534562 DOI: 10.1038/s41588-022-01061-8  0.685
2022 Chen WC, Lafreniere M, Phuong C, Liu SJ, Baal JD, Lometti M, Morin O, Ziemer B, Vasudevan HN, Lucas CG, Hervey-Jumper SL, Theodosopoulos PV, Magill ST, Fogh S, Nakamura JL, ... ... Raleigh DR, et al. Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors. Journal of Neurosurgery. 1-7. PMID 35061986 DOI: 10.3171/2021.10.JNS211886  0.558
2021 Driver J, Hoffman SE, Tavakol S, Woodward E, Maury EA, Bhave V, Greenwald NF, Nassiri F, Aldape K, Zadeh G, Choudhury A, Vasudevan HN, Magill ST, Raleigh DR, Abedalthagafi M, et al. A Molecularly Integrated Grade for Meningioma. Neuro-Oncology. PMID 34508644 DOI: 10.1093/neuonc/noab213  0.558
2021 Haddad AF, Young JS, Amara D, Berger MS, Raleigh DR, Aghi MK, Butowski NA. Mouse models of glioblastoma for the evaluation of novel therapeutic strategies. Neuro-Oncology Advances. 3: vdab100. PMID 34466804 DOI: 10.1093/noajnl/vdab100  0.359
2021 Bush NAO, Young JS, Zhang Y, Dalle Ore CL, Molinaro AM, Taylor J, Clarke J, Prados M, Braunstein SE, Raleigh DR, Chang SM, Berger MS, Butowski NA. A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma. Journal of Neuro-Oncology. PMID 34125374 DOI: 10.1007/s11060-021-03781-z  0.36
2021 Susko MS, Chen WC, Vasudevan HN, Magill ST, Lucas CG, Oberheim Bush NA, Solomon DA, Theodosopoulos PV, McDermott MW, Villanueva-Meyer JE, Boreta L, Nakamura JL, Sneed PK, Braunstein SE, Raleigh DR. Letter: Patterns of Intermediate- and High-Risk Meningioma Recurrence After Treatment With Postoperative External Beam Radiotherapy. Neurosurgery. PMID 33887769 DOI: 10.1093/neuros/nyab143  0.506
2020 Lucas CG, Vasudevan HN, Chen WC, Magill ST, Braunstein SE, Jacques L, Dahiya S, Rodriguez FJ, Horvai AE, Perry A, Pekmezci M, Raleigh DR. Histopathologic findings in malignant peripheral nerve sheath tumor predict response to radiotherapy and overall survival. Neuro-Oncology Advances. 2: vdaa131. PMID 33880447 DOI: 10.1093/noajnl/vdaa131  0.561
2020 Haddad AF, Young JS, Kanungo I, Sudhir S, Chen JS, Raleigh DR, Magill ST, McDermott MW, Aghi MK. WHO Grade I Meningioma Recurrence: Identifying High Risk Patients Using Histopathological Features and the MIB-1 Index. Frontiers in Oncology. 10: 1522. PMID 32983999 DOI: 10.3389/Fonc.2020.01522  0.611
2020 Magill ST, Vasudevan HN, Seo K, Villanueva-Meyer JE, Choudhury A, John Liu S, Pekmezci M, Findakly S, Hilz S, Lastella S, Demaree B, Braunstein SE, Bush NAO, Aghi MK, Theodosopoulos PV, ... ... Raleigh DR, et al. Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma. Nature Communications. 11: 4803. PMID 32968068 DOI: 10.1038/s41467-020-18582-7  0.684
2020 Chen WC, Vasudevan HN, Choudhury A, Pekmezci M, Lucas CG, Phillips J, Magill ST, Susko MS, Braunstein SE, Oberheim Bush NA, Boreta L, Nakamura JL, Villanueva-Meyer JE, Sneed PK, Perry A, ... ... Raleigh DR, et al. A Prognostic Gene-Expression Signature and Risk Score for Meningioma Recurrence After Resection. Neurosurgery. PMID 32860417 DOI: 10.1093/Neuros/Nyaa355  0.583
2020 Prager BC, Vasudevan HN, Dixit D, Bernatchez JA, Wu Q, Wallace LC, Bhargava S, Lee D, King BH, Morton AR, Gimple RC, Pekmezci M, Zhu Z, Siqueira-Neto JL, Wang X, ... ... Raleigh DR, et al. The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies. Cancer Discovery. PMID 32703768 DOI: 10.1158/2159-8290.Cd-20-0160  0.394
2020 Findakly S, Choudhury A, Daggubati V, Pekmezci M, Lang UE, Raleigh DR. Meningioma cells express primary cilia but do not transduce ciliary Hedgehog signals. Acta Neuropathologica Communications. 8: 114. PMID 32690089 DOI: 10.1186/S40478-020-00994-7  0.34
2020 Choudhury A, Raleigh DR. Preclinical models of meningioma: Cell culture and animal systems. Handbook of Clinical Neurology. 169: 131-136. PMID 32553284 DOI: 10.1016/B978-0-12-804280-9.00008-1  0.319
2020 Vasudevan HN, Castro MRH, Lee JC, Villanueva-Meyer JE, Bush NAO, McDermott MW, Solomon DA, Perry A, Magill ST, Raleigh DR. DNA methylation profiling demonstrates superior diagnostic classification to RNA-sequencing in a case of metastatic meningioma. Acta Neuropathologica Communications. 8: 82. PMID 32517746 DOI: 10.1186/S40478-020-00952-3  0.589
2020 Liu SJ, Malatesta M, Lien BV, Saha P, Thombare SS, Hong SJ, Pedraza L, Koontz M, Seo K, Horlbeck MA, He D, Birk HS, Jain M, Olsen HE, Akeson M, ... ... Raleigh DR, et al. CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma. Genome Biology. 21: 83. PMID 32234056 DOI: 10.1186/S13059-020-01995-4  0.303
2020 Liu SJ, Magill ST, Vasudevan HN, Hilz S, Villanueva-Meyer JE, Lastella S, Daggubati V, Spatz J, Choudhury A, Orr BA, Demaree B, Seo K, Ferris SP, Abate AR, Oberheim Bush NA, ... ... Raleigh DR, et al. Multiplatform Molecular Profiling Reveals Epigenomic Intratumor Heterogeneity in Ependymoma. Cell Reports. 30: 1300-1309.e5. PMID 32023450 DOI: 10.1016/J.Celrep.2020.01.018  0.643
2020 Bhaduri A, Di Lullo E, Jung D, Müller S, Crouch EE, Espinosa CS, Ozawa T, Alvarado B, Spatazza J, Cadwell CR, Wilkins G, Velmeshev D, Liu SJ, Malatesta M, Andrews MG, ... ... Raleigh DR, et al. Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma. Cell Stem Cell. 26: 48-63.e6. PMID 31901251 DOI: 10.1016/J.Stem.2019.11.015  0.345
2019 Morin O, Chen WC, Nassiri F, Susko M, Magill ST, Vasudevan HN, Wu A, Vallières M, Gennatas ED, Valdes G, Pekmezci M, Alcaide-Leon P, Choudhury A, Interian Y, Mortezavi S, ... ... Raleigh DR, et al. Integrated models incorporating radiologic and radiomic features predict meningioma grade, local failure, and overall survival. Neuro-Oncology Advances. 1: vdz011. PMID 31608329 DOI: 10.1093/noajnl/vdz011  0.547
2019 Chapman CH, Hara JH, Molinaro AM, Clarke JL, Oberheim Bush NA, Taylor JW, Butowski NA, Chang SM, Fogh SE, Sneed PK, Nakamura JL, Raleigh DR, Braunstein SE. Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survival. Neuro-Oncology Practice. 6: 364-374. PMID 31555451 DOI: 10.1093/Nop/Npz017  0.312
2019 Sloan EA, Cooney T, Oberheim Bush NA, Buerki R, Taylor J, Clarke JL, Torkildson J, Kline C, Reddy A, Mueller S, Banerjee A, Butowski N, Chang S, Mummaneni PV, Chou D, ... ... Raleigh DR, et al. Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas. Acta Neuropathologica. PMID 31515627 DOI: 10.1007/S00401-019-02072-2  0.377
2019 Susko M, Yu Y, Ma L, Nakamura J, Fogh S, Raleigh DR, Golden E, Theodosopoulos PV, McDermott MW, Sneed PK, Braunstein SE. Preoperative Dural Contact and Recurrence Risk After Surgical Cavity Stereotactic Radiosurgery for Brain Metastases: New Evidence in Support of Consensus Guidelines. Advances in Radiation Oncology. 4: 458-465. PMID 31360800 DOI: 10.1016/J.Adro.2019.03.002  0.324
2019 Dalle Ore CL, Magill ST, Yen AJ, Shahin MN, Lee DS, Lucas CG, Chen WC, Viner JA, Aghi MK, Theodosopoulos PV, Raleigh DR, Villanueva-Meyer JE, McDermott MW. Meningioma metastases: incidence and proposed screening paradigm. Journal of Neurosurgery. 1-9. PMID 30952122 DOI: 10.3171/2019.1.Jns181771  0.555
2019 Voce DJ, Bernal GM, Wu L, Crawley CD, Zhang W, Mansour NM, Cahill KE, Szymura SJ, Uppal A, Raleigh DR, Spretz R, Nunez L, Larsen G, Khodarev NN, Weichselbaum RR, et al. Temozolomide treatment induces lncRNA MALAT1 in an NF-кB and p53 co-dependent manner in glioblastoma. Cancer Research. PMID 30940658 DOI: 10.1158/0008-5472.Can-18-2170  0.302
2019 Lee JC, Mazor T, Lao R, Wan E, Diallo AB, Hill NS, Thangaraj N, Wendelsdorf K, Samuel D, Kline CN, Banerjee A, Auguste K, Raffel C, Gupta N, Berger M, ... Raleigh DR, et al. Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma. Acta Neuropathologica. PMID 30877433 DOI: 10.1007/S00401-019-01990-5  0.547
2019 Magill ST, Shahin MN, Lucas CG, Yen AJ, Lee DS, Raleigh DR, Aghi MK, Theodosopoulos PV, McDermott MW. Surgical Outcomes, Complications, and Management Strategies for Foramen Magnum Meningiomas. Journal of Neurological Surgery. Part B, Skull Base. 80: 1-9. PMID 30733894 DOI: 10.1055/S-0038-1654702  0.62
2019 Brastianos PK, Galanis E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, Herold-Mende C, Ippen FM, Mawrin C, McDermott MW, Sloan A, Snyder J, Tabatabai G, Tatagiba M, Tonn JC, ... ... Raleigh DR, et al. Advances in multidisciplinary therapy for meningiomas. Neuro-Oncology. 21: i18-i31. PMID 30649489 DOI: 10.1093/Neuonc/Noy136  0.354
2019 Breshears JD, Liu SJ, Vasudevan H, Pekmezci M, Castro MG, Lang U, Chen W, Choudhury A, Magill ST, Braunstein S, Gopinath C, Nakamura JL, Sneed P, Perry A, McDermott MW, ... ... Raleigh DR, et al. Multiplatform Molecular Profiling of Vestibular Schwannoma Reveals 2 Subgroups of Tumors With Distinct Radiographic Features and a Methylation-Based Predictor of Local Recurrence Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_317  0.626
2019 Susko M, Vasudevan H, Magill S, Calixto-Hope L, Villanueva-Meyer J, Nakamura J, Ann Oberheim-Bush N, Theodosopoulos P, Solomon D, Braunstein S, Sneed P, McDermott M, Raleigh D. MNGI-04. PATTERNS OF FAILURE AND FACTORS INFLUENCING LOCAL RECURRENCE OF MENINGIOMA TREATED WITH POSTOPERATIVE RADIATION THERAPY Neuro-Oncology. 21: vi140-vi140. DOI: 10.1093/Neuonc/Noz175.586  0.619
2019 John Liu S, Malatesta M, Seo K, Lien B, Hong S, Koontz M, Raleigh D, Ullian E, Lim D. GENE-39. CRISPRi-BASED RADIATION MODIFIER SCREEN IDENTIFIES LONG NON-CODING RNA THERAPEUTIC TARGETS IN GLIOMA Neuro-Oncology. 21: vi106-vi106. DOI: 10.1093/Neuonc/Noz175.441  0.323
2019 John Liu S, Vasudevan H, Pekmezci M, Choudhury A, Lien B, Breshears J, Swaney D, Magill S, Lang U, Chen W, Gopinath C, Castro M, Villanueva-Meyer J, Braunstein S, Sneed P, ... ... Raleigh D, et al. GENE-37. VESTIBULAR SCHWANNOMA IS COMPRISED OF NEURAL CREST AND IMMUNE SUBGROUPS Neuro-Oncology. 21: vi105-vi105. DOI: 10.1093/Neuonc/Noz175.439  0.67
2019 Wen Fan Q, Lorenzana E, Luo X, Lea R, Aksoy O, An Z, Ozawa T, Wassarman D, Shokat K, Aggen J, Smith JAM, Singh M, Butowski N, Raleigh D, Weiss W. DDIS-33. SELECTIVE AND COMPLETE INHIBITION OF mTORC1 BY BI-STERIC mTOR INHIBITORS DRIVES THERAPEUTIC RESPONSE IN GLIOBLASTOMA Neuro-Oncology. 21: vi70-vi70. DOI: 10.1093/Neuonc/Noz175.284  0.3
2019 Magill S, Vasudevan H, Seo K, John Liu S, Hilz S, Villanueva-Meyer J, Choudhury A, Demaree B, Lim D, Braunstein S, Ann Oberheim-Bush N, Ullian E, Aghi M, Theodosopoulos P, Sneed P, ... ... Raleigh D, et al. TMOD-27. A NEURAL CREST CELL SUBPOPULATION UNDERLIES INTRATUMOR HETEROGENEITY IN MENINGIOMA Neuro-Oncology. 21: vi268-vi268. DOI: 10.1093/Neuonc/Noz175.1126  0.7
2019 Krishna S, Kakaizada S, Valdivia C, Seo K, Raleigh D, Findlay A, Almeida N, Sudharshan R, Choudhury A, Brang D, Nagarajan S, Berger M, Monje M, Hervey-Jumper S. TMIC-46. GLIOMA-INDUCED SYNAPTOGENESIS IS ENRICHED WITHIN FUNCTIONAL CONNECTIVITY NETWORK HUBS AND INFLUENCES LANGUAGE PROCESSING IN ADULT IDH WT GLIOBLASTOMA Neuro-Oncology. 21: vi257-vi258. DOI: 10.1093/Neuonc/Noz175.1080  0.43
2019 Liu SJ, Magill S, Vasudevan H, Hilz S, Daggubati V, Villanueva-Meyer J, Choudhury A, Ferris S, Orr B, Bush NAO, Bollen A, McDermott M, Costello J, Raleigh D. EPEN-02. MULTIPLATFORM MOLECULAR PROFILING REVEALS INTRATUMOR HETEROGENEITY IN EPENDYMOMA Neuro-Oncology. 21: ii77-ii78. DOI: 10.1093/Neuonc/Noz036.061  0.638
2019 Vasudevan H, Lucas C, Liu S, Choudhury A, Magill S, Gopinath C, Nakamura J, Braunstein S, Perry A, Pekmezci M, Raleigh D. Postoperative Radiation Therapy Improves Progression-Free Survival in Malignant Peripheral Nerve Sheath Tumors International Journal of Radiation Oncology*Biology*Physics. 105: E801-E802. DOI: 10.1016/J.Ijrobp.2019.06.2494  0.591
2019 Liu S, Vasudevan H, Breshears J, Pekmezci M, Villanueva-Meyer J, Lang U, Chen W, Choudhury A, Magill S, Braunstein S, Gopinath C, Nakamura J, Tward A, Sneed P, Perry A, ... ... Raleigh D, et al. Multiplatform Molecular Profiling of Vestibular Schwannoma Reveals Immune Enrichment after Radiosurgery and a Methylation-Based Predictor of Recurrence International Journal of Radiation Oncology*Biology*Physics. 105: E67. DOI: 10.1016/J.Ijrobp.2019.06.2415  0.574
2018 Fritchie K, Jensch K, Moskalev EA, Caron A, Jenkins S, Link M, Brown PD, Rodriguez FJ, Guajardo A, Brat D, Velázquez Vega JE, Perry A, Wu A, Raleigh DR, Santagata S, et al. The impact of histopathology and NAB2-STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytoma. Acta Neuropathologica. PMID 30584643 DOI: 10.1007/S00401-018-1952-6  0.364
2018 Magill ST, Dalle Ore CL, Diaz MA, Jalili DD, Raleigh DR, Aghi MK, Theodosopoulos PV, McDermott MW. Surgical outcomes after reoperation for recurrent non-skull base meningiomas. Journal of Neurosurgery. 1-9. PMID 30544357 DOI: 10.3171/2018.6.JNS18118  0.586
2018 Gennatas ED, Wu A, Braunstein SE, Morin O, Chen WC, Magill ST, Gopinath C, Villaneueva-Meyer JE, Perry A, McDermott MW, Solberg TD, Valdes G, Raleigh DR. Preoperative and postoperative prediction of long-term meningioma outcomes. Plos One. 13: e0204161. PMID 30235308 DOI: 10.1371/Journal.Pone.0204161  0.594
2018 Hara JH, Wu A, Villanueva-Meyer JE, Valdes G, Daggubati V, Mueller S, Solberg TD, Braunstein SE, Morin O, Raleigh DR. Clinical Applications of Quantitative 3-Dimensional MRI Analysis for Pediatric Embryonal Brain Tumors. International Journal of Radiation Oncology, Biology, Physics. PMID 30108003 DOI: 10.1016/J.Ijrobp.2018.05.077  0.316
2018 Magill ST, Lee DS, Yen AJ, Lucas CG, Raleigh DR, Aghi MK, Theodosopoulos PV, McDermott MW. Surgical outcomes after reoperation for recurrent skull base meningiomas. Journal of Neurosurgery. 1-8. PMID 29726777 DOI: 10.3171/2017.11.Jns172278  0.625
2018 Magill ST, Rick JW, Chen WC, Haase DA, Raleigh DR, Aghi MK, Theodosopoulos PV, McDermott MW. Petrous Face Meningiomas: Classification, Clinical Syndromes and Surgical Outcomes. World Neurosurgery. PMID 29626689 DOI: 10.1016/J.Wneu.2018.03.194  0.589
2018 Chen WC, Magill ST, Wu A, Vasudevan HN, Morin O, Aghi MK, Theodosopoulos PV, Perry A, McDermott MW, Sneed PK, Braunstein SE, Raleigh DR. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy. Journal of Neurosurgery. 1-8. PMID 29624151 DOI: 10.3171/2017.9.Jns171609  0.592
2018 Vasudevan HN, Braunstein SE, Phillips JJ, Pekmezci M, Tomlin BA, Wu A, Reis GF, Magill ST, Zhang J, Feng FY, Nicholaides T, Chang SM, Sneed PK, McDermott MW, Berger MS, ... ... Raleigh DR, et al. Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation. Cell Reports. 22: 3672-3683. PMID 29590631 DOI: 10.1016/J.Celrep.2018.03.013  0.668
2018 Chen WC, Hara J, Magill ST, Wu A, Aghi MK, Theodosopoulos PV, Perry A, McDermott MW, Sneed PK, Raleigh DR, Braunstein SE. Salvage therapy outcomes for atypical meningioma. Journal of Neuro-Oncology. PMID 29480505 DOI: 10.1007/S11060-018-2813-9  0.621
2018 Raleigh DR, Choksi PK, Krup AL, Mayer W, Santos N, Reiter JF. Hedgehog signaling drives medulloblastoma growth via CDK6. The Journal of Clinical Investigation. 128: 120-124. PMID 29202464 DOI: 10.1172/Jci92710  0.303
2018 Fritchie K, Jensch K, Jenkins S, Link M, D Brown P, Rodriguez F, Guajardo A, Brat D, Velazquez Vega J, Perry A, Wu A, Raleigh D, Santagata S, Louis D, Brastianos P, et al. RARE-08. GRADING CONSIDERATIONS FOR MENINGEAL SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA Neuro-Oncology. 20: vi237-vi238. DOI: 10.1093/Neuonc/Noy148.985  0.339
2018 Chapman C, Hara J, Clarke J, Butowski N, Chang S, Fogh S, Sneed P, Nakamura J, Raleigh D, Braunstein S. Rthp-11. Reirradiation Of Recurrent High Grade Gliomas: Outcomes And Prognostic Factors Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.943  0.324
2018 Hara J, Wu A, Villanueva-Meyer J, Valdes G, Daggubati V, Mueller S, Solberg T, Braunstein S, Morin O, Raleigh D. NIMG-67. CLINICAL APPLICATIONS OF QUANTITATIVE THREE-DIMENSIONAL MRI ANALYSIS FOR PEDIATRIC EMBRYONAL BRAIN TUMORS Neuro-Oncology. 20: vi191-vi191. DOI: 10.1093/Neuonc/Noy148.791  0.304
2018 Chen W, Lucas C, Baal J, Magill S, Wu A, Hara J, Morin O, Gopinath C, Braunstein S, Oberheim Bush NA, McDermott M, Perry A, Solomon D, Villanueva-Meyer J, Raleigh D. MNGI-30. RADIOLOGIC FEATURES ARE PROGNOSTIC FOR CLINICAL OUTCOMES OF CHORDOID MENINGIOMA Neuro-Oncology. 20: vi155-vi155. DOI: 10.1093/Neuonc/Noy148.646  0.567
2018 Morin O, Chen W, Gennatas E, Magill S, Wu A, Valdes G, Perry A, Sneed P, McDermott M, Solberg T, Bush NAO, Braunstein S, Villanueva-Meyer J, Raleigh D. MNGI-23. PREOPERATIVE QUANTITATIVE IMAGING FEATURES ARE PROGNOSTIC FOR MENINGIOMA OUTCOMES Neuro-Oncology. 20: vi153-vi154. DOI: 10.1093/Neuonc/Noy148.639  0.57
2018 Dalle Ore C, Magill S, Yen A, Shahin M, Lee D, Lucas C, Viner J, Aghi M, Theodosopoulos P, Raleigh D, Villanueva-Meyer J, McDermott M. MNGI-06. MENINGIOMA METASTASES: INCIDENCE AND SCREENING IN 1203 PATIENTS Neuro-Oncology. 20: vi149-vi149. DOI: 10.1093/Neuonc/Noy148.622  0.534
2018 Villanueva-Meyer J, Magill S, Probst K, Bush NAO, Raleigh D, Theodosopoulos P, Aghi M, McDermott M. MNGI-04. A PROPOSED IMAGING-BASED NOMENCLATURE SYSTEM FOR MENINGIOMAS Neuro-Oncology. 20: vi148-vi148. DOI: 10.1093/Neuonc/Noy148.620  0.529
2018 Magill S, Liu J, Vasudevan H, Hilz S, Ferris S, Ann N, Bush O, Villanueva-Meyer J, Bollen A, Costello J, McDermott M, Raleigh D. GENE-31. MULTIPLATFORM MOLECULAR PROFILING AND QUANTITATIVE IMAGING OF AN ANAPLASTIC EPENDYMOMA REVEALS INTRATUMORAL HETEROGENEITY Neuro-Oncology. 20: vi110-vi110. DOI: 10.1093/Neuonc/Noy148.457  0.632
2018 Morin O, Chen W, Villanueva-Meyer J, Gennatas E, Wu A, Cha S, Magill S, Perry A, Sneed P, McDermott M, Solberg T, Valdes G, Braunstein S, Raleigh D. Point-of-Care Local Failure and Overall Survival Prediction Models for Meningioma International Journal of Radiation Oncology*Biology*Physics. 102: e306-e307. DOI: 10.1016/J.Ijrobp.2018.07.962  0.548
2018 Chen W, Hara J, Magill S, Wu A, Aghi M, Theodosopoulos P, Perry A, McDermott M, Sneed P, Braunstein S, Raleigh D. Clinical Outcomes and Safety Profile of Salvage External Beam Radiation Therapy and Re-Irradiation for Recurrent Atypical Meningioma International Journal of Radiation Oncology*Biology*Physics. 102: e210. DOI: 10.1016/J.Ijrobp.2018.07.736  0.57
2018 Chapman CH, Hara J, Clarke J, Butowski NA, Chang SM, Fogh SE, Sneed PK, Nakamura JL, Raleigh D, Braunstein SE. Reirradiation of Recurrent High Grade Gliomas: Outcomes and Prognostic Factors International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.732  0.324
2018 Gennatas E, Wu A, Braunstein S, Morin O, Chen W, Magill S, Villanueva-Meyer J, Perry A, McDermott M, Solberg T, Valdes G, Raleigh D. Pre- and Postoperative Prediction of Long-Term Meningioma Outcomes International Journal of Radiation Oncology*Biology*Physics. 102: e198-e199. DOI: 10.1016/J.Ijrobp.2018.07.709  0.555
2017 Kline CN, Packer RJ, Hwang EI, Raleigh DR, Braunstein S, Raffel C, Bandopadhayay P, Solomon DA, Aboian M, Cha S, Mueller S. Case-based review: pediatric medulloblastoma. Neuro-Oncology Practice. 4: 138-150. PMID 29692919 DOI: 10.1093/Nop/Npx011  0.375
2017 Wu A, Garcia MA, Magill ST, Chen W, Vasudevan HN, Perry A, Theodosopoulos PV, McDermott MW, Braunstein SE, Raleigh DR. Presenting symptoms and prognostic factors for symptomatic outcomes following resection of meningioma. World Neurosurgery. PMID 29248774 DOI: 10.1016/J.Wneu.2017.12.012  0.59
2017 Chen W, Magill S, Wu A, Vasudevan H, Aghi M, Theodosopoulos P, Perry A, McDermott M, Sneed P, Braunstein S, Raleigh D. MNGI-09. HISTOPATHOLOGIC FEATURES PREDICT LOCAL CONTROL AFTER ADJUVANT RADIOTHERAPY FOR ATYPICAL MENINGIOMA Neuro-Oncology. 19: vi133-vi134. DOI: 10.1093/Neuonc/Nox168.547  0.563
2017 Vasudevan H, Braunstein S, Phillips JJ, Pekmezci M, Wu A, Reis G, Magill S, Chang S, Sneed P, McDermott M, Perry A, Raleigh D. GENE-04. COMPREHENSIVE GENOMIC CHARACTERIZATION OF AGGRESSIVE MENINGIOMAS IDENTIFIES MOLECULAR SIGNATURES THAT PREDICT CLINICAL OUTCOMES Neuro-Oncology. 19: vi92-vi93. DOI: 10.1093/Neuonc/Nox168.379  0.578
2017 Vasudevan H, Braunstein S, Wu A, Reis G, Magill S, Phillips J, Chang S, Sneed P, McDermott M, Perry A, Raleigh D. Molecular Profiling of Meningioma Identifies Genomic Signatures That Predict Clinical Outcomes Independent of Tumor Grade International Journal of Radiation Oncology*Biology*Physics. 99: S22. DOI: 10.1016/J.Ijrobp.2017.06.064  0.613
2016 Raleigh DR, Tomlin B, Buono BD, Roddy E, Sear K, Byer L, Felton E, Banerjee A, Torkildson J, Samuel D, Horn B, Braunstein SE, Haas-Kogan DA, Mueller S. Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients. Journal of Neuro-Oncology. PMID 27778212 DOI: 10.1016/J.Ijrobp.2017.02.198  0.347
2016 Raleigh DR, Seymour ZA, Tomlin B, Theodosopoulos PV, Berger MS, Aghi MK, Geneser SE, Krishnamurthy D, Fogh SE, Sneed PK, McDermott MW. Resection and brain brachytherapy with permanent iodine-125 sources for brain metastasis. Journal of Neurosurgery. 1-7. PMID 27367240 DOI: 10.3171/2016.4.Jns152530  0.462
2016 Raleigh DR, Solomon DA, Lloyd SA, Lazar A, Garcia MA, Sneed PK, Clarke JL, McDermott MW, Berger MS, Tihan T, Haas-Kogan DA. Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome. Neuro-Oncology. PMID 27282397 DOI: 10.1093/Neuonc/Now105  0.488
2016 Magill ST, Lau D, Raleigh DR, Sneed PK, Fogh SE, McDermott MW. Surgical Resection and Interstitial Iodine-125 Brachytherapy for High-Grade Meningiomas: A 25-Year Series. Neurosurgery. PMID 27258768 DOI: 10.1227/Neu.0000000000001262  0.589
2016 Kaprealian T, Raleigh DR, Sneed PK, Nabavizadeh N, Nakamura JL, McDermott MW. Parameters influencing local control of meningiomas treated with radiosurgery. Journal of Neuro-Oncology. PMID 27131883 DOI: 10.1007/S11060-016-2121-1  0.384
2016 Vaubel RA, Chen SG, Raleigh DR, Link MJ, Chicoine MR, Barani I, Jenkins SM, Aleff PA, Rodriguez FJ, Burger PC, Dahiya S, Perry A, Giannini C. Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature. Journal of Neuropathology and Experimental Neurology. 75: 44-52. PMID 26705409 DOI: 10.1093/Jnen/Nlv006  0.375
2015 Menke JR, Raleigh DR, Gown AM, Thomas S, Perry A, Tihan T. Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen. Acta Neuropathologica. 130: 441-3. PMID 26195322 DOI: 10.1007/S00401-015-1459-3  0.307
2015 Raleigh DR, Algazi A, Arron ST, Neuhaus IM, Yom SS. Induction Hedgehog pathway inhibition followed by combined-modality radiotherapy for basal cell carcinoma. The British Journal of Dermatology. 173: 544-6. PMID 25702621 DOI: 10.1111/Bjd.13748  0.312
2015 Barani IJ, Raleigh DR, Larson D. The management of central neurocytoma: radiotherapy. Neurosurgery Clinics of North America. 26: 45-56. PMID 25432183 DOI: 10.1016/J.Nec.2014.09.014  0.375
2015 Raleigh D, Lloyd S, Solomon D, Lazar A, Tihan T, Sneed P, Clarke J, Varenika V, Garcia M, Muller S, Berger M, Haas-Kogan D. Outcomes and Prognostic Factors for Pineal Parenchymal Tumors: A 25 Year Single-Institution Experience International Journal of Radiation Oncology*Biology*Physics. 93: E63. DOI: 10.1016/J.Ijrobp.2015.07.704  0.498
2015 Garcia M, Raleigh D, Maghsoudi K, Braunstein S, Clarke J, Sneed P, Fogh S, Larson D, Nakamura J, Barani I, Mueller S, Berger M, Haas-Kogan D. Outcomes and Salvage Therapy for Recurrent Choroid Plexus Tumors: A 25-Year Single-Institution Experience International Journal of Radiation Oncology*Biology*Physics. 93: E504. DOI: 10.1016/J.Ijrobp.2015.07.1835  0.478
2014 Raleigh DR, Haas-Kogan DA. Non-Muscle Myosin IIa Heavy Chain Links Squamous-Cell Carcinoma of the Head and Neck to the DNA Damage Response. Frontiers in Oncology. 4: 228. PMID 25202680 DOI: 10.3389/Fonc.2014.00228  0.369
2014 Chang AJ, Roach M, Gottschalk A, Cunha AJ, Seymour ZA, Johnson JA, Raleigh D, Shinohara K, Hsu IJ. Long-Term Outcomes of Patients With High-Risk Prostate Cancer Treated With HDR Brachytherapy Boost International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1406  0.31
2013 Buschmann MM, Shen L, Rajapakse H, Raleigh DR, Wang Y, Wang Y, Lingaraju A, Zha J, Abbott E, McAuley EM, Breskin LA, Wu L, Anderson K, Turner JR, Weber CR. Occludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux. Molecular Biology of the Cell. 24: 3056-68. PMID 23924897 DOI: 10.1091/Mbc.E12-09-0688  0.588
2011 Raleigh DR, Boe DM, Yu D, Weber CR, Marchiando AM, Bradford EM, Wang Y, Wu L, Schneeberger EE, Shen L, Turner JR. Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function. The Journal of Cell Biology. 193: 565-82. PMID 21536752 DOI: 10.1083/Jcb.201010065  0.755
2011 Shen L, Weber CR, Raleigh DR, Yu D, Turner JR. Tight junction pore and leak pathways: a dynamic duo. Annual Review of Physiology. 73: 283-309. PMID 20936941 DOI: 10.1146/annurev-physiol-012110-142150  0.62
2010 Yu D, Marchiando AM, Weber CR, Raleigh DR, Wang Y, Shen L, Turner JR. MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function. Proceedings of the National Academy of Sciences of the United States of America. 107: 8237-41. PMID 20404178 DOI: 10.1073/Pnas.0908869107  0.759
2010 Marchiando AM, Shen L, Graham WV, Weber CR, Schwarz BT, Austin JR, Raleigh DR, Guan Y, Watson AJ, Montrose MH, Turner JR. Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. The Journal of Cell Biology. 189: 111-26. PMID 20351069 DOI: 10.1083/Jcb.200902153  0.758
2010 Weber CR, Raleigh DR, Su L, Shen L, Sullivan EA, Wang Y, Turner JR. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. The Journal of Biological Chemistry. 285: 12037-46. PMID 20177070 DOI: 10.1074/Jbc.M109.064808  0.596
2010 Raleigh DR, Marchiando AM, Zhang Y, Shen L, Sasaki H, Wang Y, Long M, Turner JR. Tight junction-associated MARVEL proteins marveld3, tricellulin, and occludin have distinct but overlapping functions. Molecular Biology of the Cell. 21: 1200-13. PMID 20164257 DOI: 10.1091/Mbc.E09-08-0734  0.76
2009 Weber CR, Raleigh DR, Wang Y, Turner JR. T1725 Interleukin 13 (IL-13) and Tumor Necrosis Factor (TNF) Affect Distinct Components of the Tight Junction Barrier By Differing Mechanisms Gastroenterology. 136: A-566-A-567. DOI: 10.1016/S0016-5085(09)62606-8  0.466
2009 Raleigh DR, Zhang Y, Marchiando AM, Wang Y, Shen L, Long M, Turner JR. S1757 TAMPs: A Tight Junction Protein Family with Non-Redundant Functions Gastroenterology. 136: A-264. DOI: 10.1016/S0016-5085(09)61201-4  0.744
Show low-probability matches.